Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bug

Showing results (301-310 of 320) with videos related to

Pageof 32
Sort By:
The Lancet. Haematology|February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Bone Marrow Transplantation|January 31, 2018
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II TrialMichael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Bone Marrow Transplantation|January 31, 2020
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
The Journal of Clinical Investigation|May 29, 2014
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progressionRoberto Ferrarese, Griffith R Harsh, Ajay K Yadav, et al.
Bone Marrow Transplantation|March 8, 2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Journal of Hematology & Oncology|July 22, 2023
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trialMaria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, et al.
Circulation Research|July 30, 2011
Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heartRalph Knöll, Wolfgang A Linke, Peijian Zou, et al.
Neuro-Oncology|October 26, 2023
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolismMiguel Cosenza-Contreras, Agnes Schäfer, Justin Sing, et al.
European Journal of Haematology|October 14, 2024
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to DecitabineHelena Bresser, Claudia Schmoor, Olga Grishina, et al.
Pageof 32

Showing results (301-310 of 320) with videos related to

Sort By:
Pageof 32
The Lancet. Haematology|February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Bone Marrow Transplantation|January 31, 2018
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II TrialMichael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Bone Marrow Transplantation|January 31, 2020
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
The Journal of Clinical Investigation|May 29, 2014
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progressionRoberto Ferrarese, Griffith R Harsh, Ajay K Yadav, et al.
Bone Marrow Transplantation|March 8, 2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Journal of Hematology & Oncology|July 22, 2023
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trialMaria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, et al.
Circulation Research|July 30, 2011
Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heartRalph Knöll, Wolfgang A Linke, Peijian Zou, et al.
Neuro-Oncology|October 26, 2023
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolismMiguel Cosenza-Contreras, Agnes Schäfer, Justin Sing, et al.
European Journal of Haematology|October 14, 2024
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to DecitabineHelena Bresser, Claudia Schmoor, Olga Grishina, et al.
Pageof 32